Military Handheld Blood Test Device i-STAT Alinity Deployed to Middle East for Rapid TBI Diagnosis in 15 Minutes
Key Insights
The i-STAT Alinity (search) handheld blood testing device can diagnose traumatic brain injuries in just 15 minutes by measuring brain-specific proteins that cross the blood-brain barrier.
The device has received FDA approval, passed clinical trials at Walter Reed Army Institute of Research, and has been deployed to the Middle East for combat use.
Defense funding for TBI research has dropped from $175 million in fiscal 2024 to $40.5 million in fiscal 2026, raising concerns about the future pipeline of diagnostics and treatments.
The U.S. military has deployed a handheld blood testing device capable of diagnosing traumatic brain injuries in just 15 minutes to the Middle East, marking what one senior Army official called "the single most important advancement in traumatic brain injury (search) care in the last 15 to 20 years."
The device, known as the i-STAT Alinity (search), measures "brain-specific" proteins that secrete through the blood-brain barrier during a TBI. Medical providers draw blood and insert it into the device, which determines whether these proteins are elevated. If they are, the patient has sustained a brain injury. The test can detect acute brain injuries up to 24 hours after initial trauma.
Army officials noted that the i-STAT test represents one of the first service-funded research programs to start at Walter Reed Army Institute of Research, pass clinical trials, receive Food and Drug Administration (search) approval, and deploy to combat.
"This is probably the single most important advancement in traumatic brain injury (search) care in the last 15 to 20 years," said Lt. Col. Bradley A. Dengler, the neurosurgery consultant to the Army Surgeon General and director of the Military Traumatic Brain Injury Initiative at the Uniformed Services University. "Historically, we've missed a lot of these injuries."
The Diagnostic Challenge in Modern Combat
Troops have reported roughly half a million TBIs to the Pentagon since 2000, according to Defense Health Agency (search) statistics. The injury became synonymous with the Global War on Terror and blasts from improvised explosive devices. During the contemporary Iran war, the majority of the more than 500 U.S. troops injured in the Middle East sustained brain injuries, U.S. Central Command has reported.
"In Central Command, we're seeing disproportionately high traumatic brain injury (search) rates in air defense," said Col. Jessica Peck, the surgeon for 10th Army Air and Missile Defense Command. "These jobs demand extremely high cognitive performance. Even a mild traumatic brain injury can significantly degrade effectiveness, impacting coordination, emotional regulation, spatial awareness, and decision-making."
Historically, military medical providers relied on a subjective test known as the Military Acute Concussion Evaluation to assess for TBIs — a brief exam focused on memory and concentration. That approach had significant limitations.
"People can intentionally perform better or worse depending on what they want the outcome to be," Peck said. "A lot of special operations personnel have memorized the word lists, so they can essentially 'beat' the test."
The new blood-based diagnostic removes human error and cannot be duped. In a chaotic triage environment filled with unresponsive, intubated patients, "a medic can test the blood of all of them and instantly prioritize who takes the first medical evacuation seat," officials wrote.
Prolonged Field Care and Changing Battlefield Realities
The push for handheld diagnostics comes as military planners anticipate that future large-scale conflicts will require prolonged field care, where frontline medics assess, treat, stabilize, and sustain wounded troops for extended periods in austere conditions with limited resources.
This is a particularly stark issue for the Navy and Marine Corps, which operate in decentralized, maritime environments and would face significant casualties in the Pacific should a conflict arise with China. During the Global War on Terrorism, 68% of troops evacuated for head CT scans ultimately returned to duty, making evacuations to Landstuhl Regional Medical Center in Germany "a major cost in transportation as well," according to the Army.
Late last month at Camp Lejeune, North Carolina, Navy corpsmen and members of the Defense Health Agency (search) evaluated several TBI diagnostic devices in an "end user touchpoint" designed to give device developers feedback from frontline medical personnel.
"Our process is a continuum, with flexibility to evolve alongside emerging threats and meet the needs of front-line warfighters, combatant commands and joint staff," said Damien Hoffman, a product manager with DHA's Warfighter Readiness, Performance and Brain Health team. "Our goal is to rapidly develop a TBI assessment capability at the speed of relevance."
Funding Cuts Threaten Research Pipeline
Even as these diagnostic tools reach the battlefield, funding for Defense Department medical research into traumatic brain injuries has dropped by more than three-quarters over the last three fiscal years. Spending on the Pentagon-funded program to research detection and treatment of TBIs and psychological health issues fell from $175 million in fiscal 2024 to $40.5 million in fiscal 2026. The House's Defense spending bill for fiscal 2027 would not increase that funding.
"The cut in program funding for traumatic brain injuries essentially shuts down the pipeline of research needed to understand the underlying cause of these injuries," said Shannon Connell, CEO of the Invisible Wounds Foundation (search). "Until effective diagnostics and treatments can be developed, our warfighters, veterans, and their families will continue to struggle and suffer."
The fiscal 2025 continuing resolution zeroed out TBI research entirely, along with 22 other disease or disorder programs under the Congressionally Directed Medical Research Programs. While funding was partially restored in fiscal 2026, it remains less than a quarter of the fiscal 2024 level.
The U.S. government has spent more than $2.1 billion since 2015 on TBI research, according to RAND Corporation, with more than half at the Department of Health and Human Services and the rest at the Pentagon. But NIH funding has also been scaled back during the second Trump administration.
"We do not have an accurate scanning device (MRI machine) that can detect a TBI from repetitive blast exposure at the necessary microscopic levels, which we urgently need, or any FDA-approved treatments for them," Connell said. "In fairness, the science is evolving rapidly and because of that, we understand more than we did 10 years ago. We're now closer to developing a diagnostic but funding cuts limit us from getting there."
CT scans and MRI scans can rule out some of the most serious brain injuries but cannot detect all TBIs, according to the FDA. "More sensitive and objective ways to diagnose and detect mild TBI are needed," the FDA's website states.